Jiangsu (SH:688426) Xin Lang Cai Jing·2025-11-17 05:46Core Viewpoint - 康为世纪 experienced a 5.13% increase in stock price, reaching 32.80 yuan per share, with a total market capitalization of 3.69 billion yuan as of November 17 [1] Company Overview - 江苏康为世纪生物科技股份有限公司 was established on September 3, 2010, and went public on October 25, 2022 [1] - The company specializes in the research, production, and sales of molecular detection products, providing molecular detection services [1] - Revenue composition: 89.14% from product sales, 10.86% from services, and 0.00% from other sources [1] Shareholder Analysis - 融通健康产业灵活配置混合A/B (000727) reduced its holdings by 1 million shares in Q3, now holding 2.6 million shares, representing 6.84% of the circulating shares [2] - The fund has achieved a year-to-date return of 16.85% and a one-year return of 6.21% [2] - The fund manager, 万民远, has a tenure of 9 years and 86 days, with a total fund size of 5.96 billion yuan [2][4] Fund Holdings - 融通价值成长混合A (015553) reduced its holdings by 50,000 shares in Q3, currently holding 450,000 shares, which is 3.05% of the fund's net value [3] - The fund has a year-to-date return of 24.83% and a one-year return of 19.23% [3] - The fund manager, 万民远, has a tenure of 9 years and 86 days, managing a total fund size of 5.96 billion yuan [4]